سعر ميرا-سيفوفلوران 100٪ سائل للاستنشاق 250 مل 2026

Sevoflurane 100% liquid for inhalation anaesthesia, 250 ml, Amriya / Mira International (Egypt).

• Induction and/or maintenance of general anaesthesia by inhalation (sevoflurane). Hospital use only with calibrated vaporiser.Population: Adults and children (anaesthetist-supervised)WHO ATC

• Dose-dependent hypotension, respiratory depression, nausea/vomiting, shivering; rare malignant hyperthermia; hepatic injury (esp. repeated halothane); arrhythmias.General active-ingredient information · WHO ATC

• Known or suspected genetic susceptibility to malignant hyperthermia; hypersensitivity to sevoflurane or other halogenated anaesthetics where cross-sensitivity is a concern.General active-ingredient information · WHO ATC

• May trigger malignant hyperthermia in susceptible individuals — have dantrolene and MH protocol available. Use only by personnel trained in general anaesthesia with appropriate airway/ventilatory support.General active-ingredient information · WHO ATC
• Hepatotoxicity risk with repeated halogenated anaesthetic exposure (historically prominent with halothane). Monitor for unexplained fever/jaundice after anaesthesia.General active-ingredient information · WHO ATC
• Cardiovascular depression and arrhythmia risk; avoid epinephrine-containing solutions when possible with older agents such as halothane. Continuous monitoring required.General active-ingredient information · WHO ATC

• Use in pregnancy only if clearly needed under obstetric anaesthesia protocols; halogenated agents cross the placenta and can depress the neonate.General active-ingredient information · WHO ATC

• Sevoflurane: Enhances inhibitory and reduces excitatory neurotransmission via multiple CNS receptors/channels to produce general anaesthesia; low blood-gas solubility allows rapid induction/emergence.